companydata.dkY-mAbs Therapeutics A/S: Financial statements 2025
CVR: 37053678
Y-mAbs Therapeutics A/S (CVR 37053678) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 29,300,371 and a net result of DKK -38,461,598 compared with DKK -12,500,464 the year before. That is a decrease of 60.5% compared with the year before. Equity amounted to DKK -163,651,844. The company had 53 employees in the financial year.
- Gross Profit
- 29,300,371 kr.
- Profit/Loss
- -38,461,598 kr.
- Equity
- -163,651,844 kr.
- Total Assets
- 15,043,147 kr.
- Employees
- 53
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 29.3 mio. | -38.5 mio. | -163.7 mio. | 53 |
| 2024 | - | 74.3 mio. | -12.5 mio. | -125.2 mio. | 56 |
| 2023 | - | 70.7 mio. | -27.7 mio. | -112.7 mio. | 59 |
| 2022 | - | 82.3 mio. | -85.7 mio. | -84.9 mio. | 101 |
| 2021 | - | 67.5 mio. | -42.1 mio. | -39.3 mio. | 88 |
Find more companies like Y-mAbs Therapeutics A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of December 29, 2025, EY Godkendt Revisionspartnerselskab has been appointed auditor of Y-mAbs Therapeutics A/S.
As of December 29, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Antoine Bernasconi has joined the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Vincent Sainte-Catherine has joined the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Julien Forest has joined the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Johan Ernst Wedell-Wedellsborg has left the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Thomas Gad has left the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Michael Joseph Rossi has left the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Peter Paul Pfreundschuh has left the board of directors of Y-mAbs Therapeutics A/S.
As of September 29, 2025, Vincent Sainte-Catherine is registered as adm. dir. of Y-mAbs Therapeutics A/S.
About Y-mAbs Therapeutics A/S
Y-mAbs Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Vincent Sainte-Catherine. The company is owned by Y-mAbs Therapeutics, Inc.. The company has 24 employees. In 2025, the company reported a gross profit of DKK 29,300,371 and a net result of DKK -38,461,598 compared with DKK -12,500,464 the year before. Equity amounted to DKK -163,651,844.